CN104398753A - External use essential oil for treating herpes zoster sequelae - Google Patents
External use essential oil for treating herpes zoster sequelae Download PDFInfo
- Publication number
- CN104398753A CN104398753A CN201410617309.5A CN201410617309A CN104398753A CN 104398753 A CN104398753 A CN 104398753A CN 201410617309 A CN201410617309 A CN 201410617309A CN 104398753 A CN104398753 A CN 104398753A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- herpes zoster
- external use
- oil
- essence oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 21
- 239000000341 volatile oil Substances 0.000 title abstract 19
- 239000003814 drug Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 7
- 241000700605 Viruses Species 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 208000004296 neuralgia Diseases 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 241001116389 Aloe Species 0.000 abstract 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 abstract 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 235000005979 Citrus limon Nutrition 0.000 abstract 1
- 244000131522 Citrus pyriformis Species 0.000 abstract 1
- 240000000560 Citrus x paradisi Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000006927 Foeniculum vulgare Species 0.000 abstract 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 abstract 1
- 241000208152 Geranium Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000721662 Juniperus Species 0.000 abstract 1
- 244000178870 Lavandula angustifolia Species 0.000 abstract 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 abstract 1
- 240000003553 Leptospermum scoparium Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 244000042664 Matricaria chamomilla Species 0.000 abstract 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000179970 Monarda didyma Species 0.000 abstract 1
- 235000010672 Monarda didyma Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 235000011399 aloe vera Nutrition 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000001102 lavandula vera Substances 0.000 abstract 1
- 235000018219 lavender Nutrition 0.000 abstract 1
- 210000000944 nerve tissue Anatomy 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 12
- 238000000034 method Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000007958 sleep Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 201000006082 Chickenpox Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000003098 Ganglion Cysts Diseases 0.000 description 2
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000005400 Synovial Cyst Diseases 0.000 description 2
- 206010046980 Varicella Diseases 0.000 description 2
- 208000002352 blister Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an external use essential oil for treating herpes zoster sequelae. The essential oil is composed of cinnamon essential oil, fennel essential oil, mint essential oil, juniper fruit essential oil, bergamot essential oil, lavender essential oil, myrrh essential oil, aloe essential oil, chamomile essential oil, geranium essential oil, lemon essential oil, tea tree essential oil, grapefruit essential oil and fire treatment essential oil. The external use essential oil is prepared through a routine technology. The external use essential oil rapidly resists viruses, eliminates inflammations, restores damaged nerve tissues, rapidly alleviates and eliminates nerve pains caused by herpes zoster and herpes zoster sequelae, can shorten the disease course, and has substantial effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of external essence oil for the treatment of herpes zoster sequela
Background technology
Herpes zoster sequela medical terminology is called " post-herpetic neuralgia ".Herpes zoster is infected by a kind of chickenpox virus and causes, common viral dermatosis.During child's primary infection, chickenpox can be there is, or inapparent infection, after this Virus entry sensation end, also hide in the neuron of what spinal cord posterior root ganglion enduringly through mobile again, when catching a cold, malignant tumor, immune disease, acceptance radiation or chemotherapy, when resistance of human body reduces, will herpes zoster be brought out.Herpes zoster, the traditional Chinese medical science is called herpes zoster, is among the peoplely commonly called as " herpes zoster " etc., and doctor trained in Western medicine is thought and belonged to viral infection, there is no specific short so far.Primary infection virus can be hidden for a long time at spinal cord posterior root ganglion, and immunologic function weakens that can to bring out varicella zoster virus movable once again, and growth and breeding, involves skin along peripheral nerve, and herpes zoster occurs.Its clinical meeting shows as the bubble that bunch to catchment, and to troop zonal distribution, with violent neuralgia along side peripheral nerve.Herpes zoster will produce the rather thorny sequela-post-herpetic neuralgia of clinical treatment once wrong treatment, mistake are controlled and patient's autoimmunity declines.
Summary of the invention
The object of the invention is to provide a kind of external essence oil for the treatment of herpes zoster sequela.
The present invention is achieved through the following technical solutions:
The crude drug of external essence oil of the present invention consists of:
The crude drug composition of external essence oil of the present invention is preferably:
The crude drug composition of external essence oil of the present invention is preferably:
The crude drug composition of external essence oil of the present invention is preferably:
13 taste former spice quintessence oil in external essence oil of the present invention is commercially available, as Baiyun District, Guangzhou City Nuo Ya quintessence oil factory or Guangzhou Xiang Zhi commerce and trade company limited produce or sell; Described HUOLONG liquid is commercially available, and Natural medicine (group) company limited as strong in China's power produces or sells.
The preparation method of external essence oil of the present invention is: by above-mentioned raw materials medicine conveniently technique make external essence oil.
The nervous tissue that external essence oil energy Fast Anti virus of the present invention, antiinflammatory, reparation are impaired, can alleviate rapidly and eliminate the neuralgia caused by herpes zoster and sequela thereof, can also shorten the course of disease, and Be very effective.
Experimental example is used for further illustrating the present invention below, but is not limited to the present invention.
Experimental example one: clinical trial
1, clinical observation
External essence oil of the present invention (according to the preparation of embodiment 1 method) is to treatment herpes zoster sequela patient 100 example, and wherein male 50 example, women 50 is routine.
2, medicament selection
Treatment group anthology invention external essence oil (according to the preparation of embodiment 1 method), two courses for the treatment of (5 days courses for the treatment of), 30ml/ bottle, smears affected part three times on the one.
3, diagnostic criteria
Premorbid local skin first has causalgia, companion's grade fever, the tired General Symptoms such as unable.But also can absence of prodrome, after 1 ~ 3 day, skin occurs being dispersed in erythema successively.Then in erythema, there is the foxtail millet grain of most cluster greatly to the papulovesicle of Semen phaseoli radiati size, and become vesicle rapidly.Water tonic vesicle wall, light, bleb clarification of water, there is dolly dimple in large portion, vesicle surface.After a few days, bleb liquid muddiness is suppurated, and forms rotten to the corn face after ulceration, and final drying forms a scab, and leaves erythema fugax after crust comes off.The general course of disease about 2 ~ 4 weeks.
Making a definite diagnosis of herpes zoster and sequela
1. pain is in the side of health; 2. pain is the twinge of beating property; 3. painful area is not fixed; 4. painful area has heating sense; 5. pain 12 o'clock nights to 3 aggravation persons in zero morning, because herpesvirus has " when recognizing property ".
4, criterion of therapeutical effect
" in cure the desease Standardization of diagnosis and curative effect " of implementing with reference to State Administration of Traditional Chinese Medicine 1994 drafts as follows:
Clinical recovery: tcm clinical practice symptom, sign disappear or substantially disappear;
Effective: tcm clinical practice symptom, sign obviously change;
Effective: tcm clinical practice symptom, sign all take a favorable turn;
Invalid: tcm clinical practice symptom, sign are all not improved;
5, therapeutic outcome
| Group | Treatment number | Cure | Effective | Effectively | Invalid | Total effective rate |
| Treatment group | 100 | 64 | 26 | 8 | 2 | 98％ |
6, conclusion
100 routine patients use external essence oil of the present invention two courses for the treatment of (5 days each courses for the treatment of), and therapeutic outcome shows, and total effective rate is 98%.
Experimental example two: model case
Case 1: king so-and-so, man, 42 years old.Symptom: to suffer from after herpes zoster remaining left side forehead and head hurt like hell in March, in pinprick sample, burn sample pain, have a strong impact on sleep, have a medical check-up: left side forehead and head are touched a tender spot obviously, feel to go down in skin lesion region.Once treated about more than January at Neurology Department, and had no and be clearly better.Use external essence oil of the present invention (according to the preparation of embodiment 1 method) after 5 days (smearing affected part, every day three times) after being introduced, pain relief is obvious, and patient sleeps is unaffected, and rear continuation use was fully recovered after 5 days.
Case 2: Lee, female, 62 years old.Symptom: patient wakes up from a sleep and finds that oneself chest and back grows bunch collection property exanthema vesiculosum and with pain, she goes in a hurry institute of traditional Chinese medicine of province department of dermatologry to go to a doctor.After diagnosing, Mrs Wang has suffered from banded property herpes.Use external essence oil of the present invention (according to the preparation of embodiment 2 method) 5 days, rear (smearing affected part, every day three times) pain relief, rear continuation uses 3 days and thoroughly cures.
Case 3: fourth so-and-so, man, 63 years old.Symptom: early morning, patient feels that auris dextra hangs down and jumps pain, outbreak per minute for several times.After 2 hours, ear-lobe does not ache, but to feel after ear and pain around ear.Evening on the same day, pain disappeared.Next day feels severe pain once touching right side scalp.Occur blister in lower jaw part, cervical region after one day, large person is as Semen Maydis, and little person is as small rice grain.Mouth was askew left on 3rd ~ 4, and right eye does not close, and broke as belt-shaped blister sequela through rash.The application of the invention external essence oil (according to embodiment 3 method preparation) treatment a course for the treatment of after (5 days each courses for the treatment of), pain relief, mouth is not askew, right eye also can have been closed, after the course for the treatment of of rear continual cure, above-mentioned symptom disappears completely, recovery from illness.
Following embodiment all can realize the effect of above-mentioned experimental example.
Detailed description of the invention
Embodiment 1
By above-mentioned raw materials medicine conveniently technique make external essence oil.Every day smears affected part three times.
Embodiment 2
By above-mentioned raw materials medicine conveniently technique make external essence oil.Every day smears affected part three times.
Embodiment 3
By above-mentioned raw materials medicine conveniently technique make external essence oil.Every day smears affected part three times.
Claims (5)
1. treat an external essence oil for herpes zoster sequela, it is characterized in that, the crude drug of this quintessence oil consists of:
2. external essence oil as claimed in claim 1, is characterized in that the crude drug of this quintessence oil consists of:
3. external essence oil as claimed in claim 1, is characterized in that the crude drug of this quintessence oil consists of:
4. external essence oil as claimed in claim 1, is characterized in that the crude drug of this quintessence oil consists of:
5. the application of the external essence oil as described in one of claim 1-4 in the medicine of preparation treatment herpes zoster sequela.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410617309.5A CN104398753A (en) | 2014-11-06 | 2014-11-06 | External use essential oil for treating herpes zoster sequelae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410617309.5A CN104398753A (en) | 2014-11-06 | 2014-11-06 | External use essential oil for treating herpes zoster sequelae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104398753A true CN104398753A (en) | 2015-03-11 |
Family
ID=52636462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410617309.5A Pending CN104398753A (en) | 2014-11-06 | 2014-11-06 | External use essential oil for treating herpes zoster sequelae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104398753A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103495049A (en) * | 2013-09-13 | 2014-01-08 | 赵丽 | Formula of essential oil capable of relieving neuropathic pain |
-
2014
- 2014-11-06 CN CN201410617309.5A patent/CN104398753A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103495049A (en) * | 2013-09-13 | 2014-01-08 | 赵丽 | Formula of essential oil capable of relieving neuropathic pain |
Non-Patent Citations (4)
| Title |
|---|
| 冯伟玲主编: "《时尚芳香疗法精粹》", 30 November 2006, 上海科学技术文献出版社 * |
| 权健火疗师: "体用精油（火龙液）", 《权健火疗师的博客》 * |
| 杨慧华等: "火龙灸治疗老年带状疱疹后遗神经痛的效果观察", 《护理学报》 * |
| 邵海等: "植物精油在药理和农药方面的研究进展", 《中国野生植物资源》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101524513B (en) | Health pillow drug core | |
| CN106466454A (en) | A kind of prevention and the gel for the treatment of gynecological inflammation | |
| CN104288727B (en) | A kind of dedicated compound Chinese medicinal preparation of chill cold in children health care | |
| CN102430071A (en) | Medicament for treating herpes zoster | |
| CN104367757A (en) | Traditional Chinese medicine composition for treating pains in necks, shoulders, waists and legs | |
| CN104940704A (en) | Traditional Chinese medicine combination for treating pain in neck, shoulder, waist and lower extremities | |
| CN104042761A (en) | Traditional Chinese medicine (TCM) composition for treating herpes zoster | |
| CN102526307A (en) | Chinese medicinal composition for treating herpes zoster | |
| CN105168286A (en) | Externally-applied medicine for treating herpes zoster | |
| CN104398753A (en) | External use essential oil for treating herpes zoster sequelae | |
| CN104189306A (en) | Medicine used for treating peripheral facial neuritis | |
| CN104147403A (en) | Drug for preventing and treating cervical spondylosis | |
| CN103784541A (en) | Traditional Chinese medicine for treating pains on neck, shoulders, waist and legs | |
| CN107898950A (en) | A kind of Chinese medicine composition for treating eczema and preparation method thereof | |
| CN104758462B (en) | A kind of powder for the treatment of acute cholecystitis | |
| CN103585345B (en) | A kind of pharmaceutical composition being used for the treatment of herpes zoster and post herpetic neuralgia thereof | |
| CN103127209A (en) | Antiviral drug | |
| CN107890482A (en) | A kind of medicine for treating pruitus and its application | |
| CN105535056A (en) | Traditional Chinese medicine preparation for treating viral meningitis and preparation method and application thereof | |
| CN104922463B (en) | A kind of traditional Chinese medicinal ointment and preparation method thereof treated children's wind-heat and violate phenotype varicella | |
| Hoi | Herpes Virus, Causes of Infections and Preventive Methods. | |
| CN104758602A (en) | Ointment for treating shingles | |
| CN104288629A (en) | Traditional Chinese medicine composition for treating neck-shoulder and lumbocrural pain | |
| CN104825809A (en) | Medicament for treating peripheral facial paralysis | |
| CN103446221A (en) | Ointment for treating herpes zoster |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150311 |